Skip to content
Screener

Bio-Techne TECH Operating Lease Liabilities (Total)

Operating Lease Liabilities (Total) at other companies

Danaher logo
DanaherDHR
$1.3B+8.3%
10x Genomics, Inc. logo
10x Genomics, Inc.TXG
$78.8M-9.2%
Agilent Technologies logo
Agilent TechnologiesA
$187M-1.1%
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
$174.8M+4.3%
Ginkgo Bioworks logo
Ginkgo BioworksDNA
$439.87M-5.9%
Tempus AI, Inc. logo
Tempus AI, Inc.TEM
$85.36M+49.8%

Other financials

Income statement

See full
Revenue$311.4M-1.5%
Gross profit$208.3M-2.9%
Operating income$75.5M+95.0%
Net income$51.0M+126%
EPS (diluted)$0.32+129%

Balance sheet

See full
Cash & equivalents$209.8M+49.2%
Total debt$290.3M-31.4%
Total equity$2.1B+3.3%
Total assets$2.6B-3.5%

Cash flow

See full
Operating cash flow$86.7M+111%
CapEx$9.1M-10.2%
Free cash flow$77.6M+150%

Valuation

See full
Market cap$11.2B+43.3%
Enterprise value$11.28B+39.3%
P/E74.8×+16.8×
P/S9.3×+2.8×

Profitability

See full
Gross margin65%-0.8pp
Operating margin14.2%-7.9pp
Net margin10.9%-6.7pp
FCF margin22.3%+4.0pp

Returns & leverage

See full
Return on equity6.5%-3.9pp
Debt / equity0.1×-0.1×
Current ratio4.5×+0.8×

Where this comes from

Reported directly by Bio-Techne in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseLiability.

The source filing: Bio-Techne’s 10-Q, filed May 6, 2026.

Filed
May 6, 2026, 4:31 PM EDT
Fiscal quarter
Q3 FY2026
Calendar quarter
Q1 2026
Accession
0001104659-26-056302
Line itemQuarter Ended / March 31, 2026Quarter Ended / March 31, 2025Nine Months Ended / March 31, 2026Nine Months Ended / March 31, 2025
Condensed Consolidated Balance SheetsMarch 31,June 30,
Lease Assets and Liabilities20262025
Operating lease ROU assets$68,31673,399
Operating lease liabilities - current$14,18114,098
Operating lease liabilities - long-term76,14183,960
Total operating lease liabilities$90,32298,058
Weighted average remaining lease term:7.0 years7.6 years
Weighted average discount rate:4.34.3

Item 1. Condensed Consolidated Financial Statements (Unaudited)

FAQ

What is Bio-Techne's operating lease liabilities (total)?
Bio-Techne (TECH) reported operating lease liabilities (total) of $90.32M in Q1 2026.
How has Bio-Techne's operating lease liabilities (total) changed year-over-year?
Bio-Techne's operating lease liabilities (total) decreased by 3.4% year-over-year, from $93.5M to $90.32M.
What is the long-term trend for Bio-Techne's operating lease liabilities (total)?
Over 3 years (2022 to 2025), Bio-Techne's operating lease liabilities (total) has grown at a 11.9% compound annual growth rate (CAGR), from $70.06M to $98.06M.
What does operating lease liabilities (total) mean?
This represents the total present value of future lease payments for operating leases, recognized as a liability on the balance sheet. It reflects the company's long-term commitment to leased assets such as office space, warehouses, and equipment. Tracking this helps investors evaluate the company's off-balance-sheet financing obligations and overall debt-like commitments.

Ask your AI about Bio-Techne's operating lease liabilities (total).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude